Key result
Standard 9-month anti-TB chemotherapy successfully treated a pericardial tuberculoma presenting as a chest wall mass, leading to complete disappearance of the mass.
Case Report (n=1)
No
Cardiac tuberculoma should be considered in the differential diagnosis of patients presenting with a thoracic wall mass, especially in endemic regions, and can be successfully treated with standard anti-TB chemotherapy.
Cardiac tuberculoma merits consideration in endemic thoracic masses; extends sparse case evidence but leaves open prospective validation.
INTRODUCTION: Tuberculosis (TB) can present both in its pulmonary or extra-pulmonary forms. Cardiac tuberculoma previously described only after autopsy is continuously seen with the advent of more advanced imaging modalities. CASE REPORT: A 23-year-old male with a four month history of a progressively increasing left anterior thoracic wall mass of 5 cm in diameter was referred from oncology for clinical re-evaluation and for echocardiography. Systemic examination was essentially normal. Transthoracic and trans-oesophageal echocardiography showed the presence of a pericardial mass around the right atrioventricular junction. Thoracic CT scan showed an anterior mass in left chest wall extending to the pericardium and also the presence of mediastinal lymphadenopathy. Mantoux test was positive and histological examination of tissue biopsy confirmed the presence of TB. However, blood tests and culture of aspirated purulent fluid were unyielding. A diagnosis of pericardial tuberculoma with mediastinal and parietal extension was made and patient was successfully treated with standard anti-TB chemotherapy. DISCUSSION: The possible differential diagnoses for chest wall tumors are varied and a high degree of suspicion is needed to diagnose cardiac tuberculoma especially in endemic regions. Imaging though helpful in morphological description cannot make precise diagnosis. The diagnosis depends on histological and culture studies. There is usually a good evolution with anti-TB treatment. CONCLUSION: In an era of an increasing number of acquired immune-compromised patients, and with increasing number of diagnoses of tuberculosis, a diagnosis of cardiac tuberculoma should be considered in patients presenting with a thoracic wall mass.
No takes yet. Share an insight, caveat, or question.
Lèye et al. (2013) conducted a case report in Pericardial tuberculoma (n=1). Standard anti-TB chemotherapy was evaluated on Resolution of the mass. Standard 9-month anti-TB chemotherapy successfully treated a pericardial tuberculoma presenting as a chest wall mass, leading to complete disappearance of the mass.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: